As anticipated with the progressive nature of the disease after 2 years in the study, half of the patients who had diabetes for >10 years at baseline were taking OAD + insulin and those who had diabetes for ≤10 years at baseline were predominantly on OADs. The gene discussed is INS; the disease is diabetes mellitus.